Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), Mario Boccadoro(University of Turin)

Journal of Clinical Oncology

February 1, 2011

10.1200/jco.2010.31.6844

Cited by 321

Related Papers

International Staging System for Multiple Myeloma

|Journal of Clinical Oncology|2005|2.9k

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

|Leukemia|2007|839

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

|Leukemia|2008|808

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

|Leukemia|2011|721

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

|Blood|2011|450